Medical Book

See Also

Asbestos News Network


Thursday 20th of November 2008

Human Growth Hormone > Saizen > Switzerland

Please select a HGH news story from the list below:

Business Wire - Merck Serono and Flamel to Collaborate on an Extended Release Formulation for Therapeutic Proteins

Thursday 20th of December 2007

December 20, 2007 -- Flamel's Medusa([R]) technology designed to allow less frequent administration of therapeutic proteins and peptides LYON, France -- Flamel...

PR Newswire Europe - FDA Approval of easypod(R): New Electronic Growth Hormone Injection Device.

Thursday 8th of November 2007

November 8, 2007 -- GENEVA, Switzerland, November 8 /PRNewswire/ -- - Innovative Device Designed for Simple Everyday Use by Patients and Caregivers Merck...

Business Wire - Serono And IVAX To Develop Oral Therapy For Multiple Sclerosis

Wednesday 30th of October 2002

October 30, 2002 -- Business Editors/Health & Medical Writers GENEVA, Switzerland & MIAMI--(BUSINESS WIRE)--Oct. 30, 2002 Serono S.A. (virt-x: SEO)...

Business Wire - Serono Selects Manugistics' Collaborative Planning & iHub Solutions

Tuesday 2nd of April 2002

April 2, 2002 -- Business Editors/Hi-Tech Writers BASEL, Switzerland--(BUSINESS WIRE)--April 2, 2002 Manugistics Group, Inc. (Nasdaq:MANU), the leading global...

Business Wire - Serono Subscribes to Celera's Genomic Databases

Thursday 20th of December 2001

December 20, 2001 -- Business Editors/Medical & Health Writers BIOWIRE2K ROCKVILLE, MD, and GENEVA, Switzerland--(BW HealthWire)--Dec. 20, 2001 Celera Genomics...

Business Wire - Palatin Enters Research Agreement With Serono to Generate Compounds Using Palatin's MIDAS Drug Design Technology

Monday 1st of October 2001

October 1, 2001 -- Business Editors & Health/Medical Writers PRINCETON, N.J.--(BW HealthWire)--Oct. 1, 2001 Palatin Technologies, Inc. (AMEX: PTN) announced today...

Business Wire - Alkermes and Serono to Proceed With Development of Long-acting Formulation of Recombinant Human Follicle Stimulating Hormone - R-hFSH

Wednesday 16th of May 2001

May 16, 2001 -- Business Editors & Health/Medical Writers BIOWIRE2K CAMBRIDGE, Mass. and GENEVA, Switzerland--(BW HealthWire)--May 16, 2001 Alkermes, Inc.,...

Business Wire - Alkermes Announces Completion of Patient Enrollment in Phase I Clinical Trial of Injectable Sustained Release Formulation of Serono Drug

Wednesday 29th of November 2000

November 29, 2000 -- Business Editors/Health & Medical Writers CAMBRIDGE, Mass.--(BW HealthWire)--Nov. 29, 2000 Alkermes, Inc. (NASDAQ:ALKS) announced today that...

Business Wire - Serono & British Biotech To Collaborate On Inflammatory Diseases

Tuesday 17th of October 2000

October 17, 2000 -- Business Editors/Medical Writers GENEVA, Switzerland & OXFORD, United Kingdom--(BUSINESS WIRE)--Oct. 17, 2000--Serono S.A. (SWX: SEO and NYSE:...

Business Wire - Bio-Technology General and Serono Laboratories Announce Co-Promotional Agreement for Serono's Line of Pediatric Growth Products

Tuesday 19th of May 1998

May 19, 1998 -- ISELIN, N.J.--(BUSINESS WIRE)--May 19, 1998--Bio-Technology General Corp. (NASDAQ:BTGC) and Serono Laboratories, Inc., U.S. member of The Ares-Serono...

Cities

Province/States

Countries


About

Our goal is to spread human growth hormone information in the form of general information and useful HGH articles from a wide variety of print publications.


Add a Bookmark

If we've proved to be a useful resource why not now?


designed: expert answers